Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype

Paraiso, Kim H. T.; Das Thakur, Meghna; Fang, Bin; Koomen, John M.; Fedorenko, Inna V.; John, Jobin K.; Tsao, Hensin; Flaherty, Keith T.; Sondak, Vernon K.; Messina, Jane L.; Pasquale, Elena B.; Villagra, Alejandro; Rao, Uma N.; Kirkwood, John M.; Meier, Friedegund; Sloot, Sarah; Gibney, Geoffrey T.; Stuart, Darrin; Tawbi, Hussein; Smalley, Keiran S. M.

dc.contributor.author	Meier, Friedegund
dc.date.accessioned	2015-12-03T12:34:19Z
dc.date.available	2015-12-03T12:34:19Z
dc.date.issued	2015
dc.identifier.issn	2159-8274
dc.identifier.uri	http://hdl.handle.net/10900/66811
dc.language.iso	en	de_DE
dc.publisher	Amer Assoc Cancer Research	de_DE
dc.relation.uri	http://dx.doi.org/10.1158/2159-8290.CD-14-0293	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_01369
utue.publikation.seiten	264-273	de_DE
utue.personen.roh	Paraiso, Kim H. T.
utue.personen.roh	Das Thakur, Meghna
utue.personen.roh	Fang, Bin
utue.personen.roh	Koomen, John M.
utue.personen.roh	Fedorenko, Inna V.
utue.personen.roh	John, Jobin K.
utue.personen.roh	Tsao, Hensin
utue.personen.roh	Flaherty, Keith T.
utue.personen.roh	Sondak, Vernon K.
utue.personen.roh	Messina, Jane L.
utue.personen.roh	Pasquale, Elena B.
utue.personen.roh	Villagra, Alejandro
utue.personen.roh	Rao, Uma N.
utue.personen.roh	Kirkwood, John M.
utue.personen.roh	Meier, Friedegund
utue.personen.roh	Sloot, Sarah
utue.personen.roh	Gibney, Geoffrey T.
utue.personen.roh	Stuart, Darrin
utue.personen.roh	Tawbi, Hussein
utue.personen.roh	Smalley, Keiran S. M.
dcterms.isPartOf.ZSTitelID	Cancer Discovery	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	5	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE